Related Experiment Video
Updated: Jun 17, 2026

09:13
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
Dysregulated microRNAs in neurodegenerative disorders
1Center for Human Genetics. K.U. Leuven. Herestraat 49 Bus 602 B-3000 Leuven, Belgium.
Seminars in Cell & Developmental Biology
|January 19, 2010
Summary
MicroRNAs regulate neural cell types and are linked to neurodegenerative diseases like Alzheimer's. Studying these microRNAs may reveal key proteins and molecular networks driving these conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neural circuit complexity depends on diverse cell types.
- MicroRNAs regulate gene expression post-transcriptionally, influencing neural cell phenotype.
- A growing body of evidence links microRNAs to neurodegenerative diseases.
Purpose of the Study:
- To review the role of microRNAs in neurodegeneration.
- To explore microRNA involvement across model organisms and human disorders.
- To propose microRNA-mRNA target analysis for identifying disease mechanisms.
Main Methods:
- Literature review and synthesis of existing research.
- Discussion of studies using model organisms (fruit fly, mouse).
- Analysis of dysregulated microRNAs in human neurodegenerative disorders.
Main Results:
- MicroRNAs are critical regulators of neural cell identity.
- MicroRNA dysregulation is implicated in Alzheimer's, Huntington's, and Parkinson's diseases.
- Evidence spans from model systems to human pathology.
Conclusions:
- MicroRNAs are key players in neurodegeneration.
- Investigating microRNAs and their mRNA targets can identify crucial proteins.
- This research may uncover molecular networks underlying neurodegenerative diseases.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

